| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| X4011 |
State-specific procedure code |
16,664 |
15,418 |
$5.06M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
15,608 |
14,972 |
$2.32M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,682 |
8,217 |
$1.76M |
| D7999 |
|
320 |
319 |
$1.28M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
20,738 |
18,985 |
$1.22M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
13,383 |
12,580 |
$1.09M |
| 80053 |
Comprehensive metabolic panel |
18,716 |
17,257 |
$931K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,622 |
3,088 |
$752K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
12,759 |
12,554 |
$657K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,758 |
5,417 |
$618K |
| X4006 |
|
213 |
199 |
$583K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
7,041 |
6,869 |
$559K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,281 |
1,195 |
$430K |
| X4003 |
|
5,519 |
5,283 |
$352K |
| 71046 |
Radiologic examination, chest; 2 views |
1,514 |
1,460 |
$340K |
| 81001 |
|
6,754 |
6,416 |
$317K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
2,677 |
2,597 |
$304K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,701 |
6,633 |
$274K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,308 |
4,913 |
$240K |
| 81025 |
|
3,752 |
3,598 |
$202K |
| 71045 |
Radiologic examination, chest; single view |
4,699 |
4,440 |
$186K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
9,920 |
1,237 |
$148K |
| 81003 |
|
3,843 |
3,631 |
$127K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
2,800 |
2,605 |
$107K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,337 |
2,042 |
$105K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,458 |
2,310 |
$85K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
6,868 |
6,582 |
$83K |
| 87428 |
|
3,045 |
2,980 |
$68K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
553 |
374 |
$63K |
| 87807 |
|
503 |
483 |
$56K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,704 |
1,610 |
$37K |
| 82962 |
|
884 |
293 |
$36K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
162 |
148 |
$35K |
| 90832 |
Psychotherapy, 30 minutes with patient |
1,431 |
1,078 |
$34K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
655 |
613 |
$32K |
| 80306 |
|
441 |
308 |
$29K |
| G0378 |
Hospital observation service, per hour |
143 |
127 |
$29K |
| 0240U |
|
340 |
328 |
$28K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,117 |
988 |
$20K |
| 90834 |
Psychotherapy, 45 minutes with patient |
242 |
161 |
$19K |
| 84484 |
|
2,222 |
1,922 |
$19K |
| 83690 |
|
1,637 |
1,555 |
$19K |
| 83735 |
|
1,462 |
1,350 |
$17K |
| J3490 |
Unclassified drugs |
2,106 |
1,626 |
$15K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
110 |
99 |
$15K |
| 80050 |
General health panel |
145 |
132 |
$15K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,194 |
1,159 |
$13K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
916 |
907 |
$9K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
81 |
81 |
$9K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
380 |
333 |
$9K |
| 80061 |
Lipid panel |
430 |
381 |
$8K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
14 |
14 |
$7K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
463 |
418 |
$7K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
83 |
83 |
$5K |
| 62323 |
|
14 |
14 |
$4K |
| 83880 |
|
207 |
192 |
$4K |
| 70450 |
Computed tomography, head or brain; without contrast material |
53 |
52 |
$3K |
| 72100 |
|
43 |
39 |
$3K |
| 87081 |
|
689 |
677 |
$3K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
51 |
51 |
$2K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
725 |
698 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
13 |
13 |
$2K |
| 83605 |
|
225 |
203 |
$2K |
| Q3014 |
Telehealth originating site facility fee |
134 |
116 |
$2K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
103 |
102 |
$1K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
13 |
13 |
$1K |
| 85379 |
|
12 |
12 |
$118.23 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
16 |
16 |
$82.76 |
| 85610 |
|
28 |
26 |
$32.59 |
| 85730 |
|
14 |
12 |
$21.64 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
38 |
26 |
$0.01 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
12 |
12 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
14 |
12 |
$0.00 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
13 |
13 |
$0.00 |